APA (7th ed.) Citation

Wu, M., Chen, Y., Hua, G., & Chunhui, L. (2023). The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches. Immunity, Inflammation & Disease, 11(10), 1. https://doi.org/10.1002/iid3.1022

Chicago Style (17th ed.) Citation

Wu, Mingwei, Yiyuan Chen, Gao Hua, and Liu Chunhui. "The CD2–CD58 Axis: A Novel Marker Predicting Poor Prognosis in Patients with Low‐grade Gliomas and Potential Therapeutic Approaches." Immunity, Inflammation & Disease 11, no. 10 (2023): 1. https://doi.org/10.1002/iid3.1022.

MLA (9th ed.) Citation

Wu, Mingwei, et al. "The CD2–CD58 Axis: A Novel Marker Predicting Poor Prognosis in Patients with Low‐grade Gliomas and Potential Therapeutic Approaches." Immunity, Inflammation & Disease, vol. 11, no. 10, 2023, p. 1, https://doi.org/10.1002/iid3.1022.